Hormone therapyPhase 3 trialInvestigational
APC-4037
Generic name: apalutamide
How it works
Blocks androgens from binding to prostate cancer cells, slowing growth.
Cancer types
Prostate Cancer— All patients
Efficacy
Studies are ongoing to evaluate the efficacy and safety of APC-4037 in men with metastatic prostate cancer.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Testing a New Treatment for Advanced Prostate Cancer | Prostate Cancer | phase-2 | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.